These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 8263813

  • 1. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P, Langston JW, Di Monte DA.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A, Fascetti F, Corsini GU, Piccardi MP.
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [Abstract] [Full Text] [Related]

  • 4. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB, Reuben M.
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 8. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS, Fung YK, Trobough KL, Cashman JR, Wilson JA.
    Neurotoxicology; 1991 Oct; 12(2):189-99. PubMed ID: 1956580
    [Abstract] [Full Text] [Related]

  • 9. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
    Vaglini F, Fascetti F, Tedeschi D, Cavalletti M, Fornai F, Corsini GU.
    Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N, Ferger B.
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [Abstract] [Full Text] [Related]

  • 11. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 12. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK.
    J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
    [Abstract] [Full Text] [Related]

  • 13. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 14. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 05; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 15. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice.
    Tabatabaei A, Perry TL, Hansen S, Krieger C.
    Neurosci Lett; 1992 Jul 20; 141(2):192-4. PubMed ID: 1436633
    [Abstract] [Full Text] [Related]

  • 16. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.
    Miller DB, O'Callaghan JP.
    J Pharmacol Exp Ther; 1994 Aug 20; 270(2):752-60. PubMed ID: 8071868
    [Abstract] [Full Text] [Related]

  • 17. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK, Keyghobadi M, Moore C, Meshul CK.
    Neuroscience; 2005 Aug 20; 136(1):333-41. PubMed ID: 16198485
    [Abstract] [Full Text] [Related]

  • 18. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
    Sheng JG.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug 20; 22(4):213-5, 253. PubMed ID: 2575971
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
    Araki T, Kumagai T, Matsubara M, Ido T, Imai Y, Itoyama Y.
    Metab Brain Dis; 2000 Sep 20; 15(3):193-201. PubMed ID: 11206588
    [Abstract] [Full Text] [Related]

  • 20. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity.
    Nwanze E, Souverbie F, Jonsson G, Sundström E.
    Neurotoxicology; 1995 Sep 20; 16(3):469-77. PubMed ID: 8584278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.